Dr. Lal Pathlabs
- Advice
- Hold
Dr. Lal Pathlabs Performance
Day Range
- Low 2,642.55
- High 2,685.75
52 Week Range
- Low 1,762.05
- High 2,767.10
- Open Price2,652.80
- Previous Close2,647.55
- Volume189857
Start SIP in Dr. Lal Pathlabs
Start SIPDr. Lal Pathlabs Investment Rating
-
Master Rating:
-
Dr Lal Pathlabs has an operating revenue of Rs. 2,122.70 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of 17% is great, ROE of 14% is good. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 21% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Services and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 532 | 480 | 431 | 428 | 467 | 439 | 415 |
Operating Expenses Qtr Cr | 369 | 344 | 315 | 324 | 337 | 330 | 310 |
Operating Profit Qtr Cr | 163 | 136 | 116 | 104 | 130 | 109 | 105 |
Depreciation Qtr Cr | 19 | 18 | 21 | 21 | 21 | 19 | 22 |
Interest Qtr Cr | 7 | 7 | 8 | 8 | 10 | 8 | 11 |
Tax Qtr Cr | 38 | 32 | 27 | 22 | 28 | 22 | 20 |
Net Profit Qtr Cr | 113 | 94 | 71 | 62 | 79 | 80 | 65 |
Dr. Lal Pathlabs Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 15
- Bearish Moving Average
- ___
- 1
- 20 Day
- ₹2,630.63
- 50 Day
- ₹2,532.79
- 100 Day
- ₹2,422.48
- 200 Day
- ₹2,335.85
- 20 Day
- ₹2,643.93
- 50 Day
- ₹2,525.43
- 100 Day
- ₹2,412.10
- 200 Day
- ₹2,190.18
Dr. Lal Pathlabs Resistance and Support
Resistance | |
---|---|
First Resistance | 2,688.98 |
Second Resistance | 2,708.97 |
Third Resistance | 2,732.18 |
RSI | 56.44 |
MFI | 53.94 |
MACD Single Line | 57.09 |
MACD | 48.86 |
Support | |
---|---|
First Resistance | 2,645.78 |
Second Resistance | 2,622.57 |
Third Resistance | 2,602.58 |
Dr. Lal Pathlabs Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 191,330 | 11,558,245 | 60.41 |
Week | 289,456 | 11,725,852 | 40.51 |
1 Month | 346,970 | 12,126,595 | 34.95 |
6 Month | 278,787 | 10,315,106 | 37 |
Dr. Lal Pathlabs Result Highlights
Dr. Lal Pathlabs Synopsis
NSE-Medical-Services
Dr. Lal Pathlabs Ltd is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 1769.03 Cr. and Equity Capital is Rs. 83.37 Cr. for the Year ended 31/03/2023. Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388.Market Cap | 22,280 |
Sales | 1,871 |
Shares in Float | 3.76 |
No of funds | 290 |
Yield | 0.45 |
Book Value | 13.17 |
U/D Vol ratio | 1.9 |
LTDebt / Equity | 5 |
Alpha | 0.03 |
Beta | 0.68 |
Dr. Lal Pathlabs
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 54.61% | 55.01% | 55.03% | 55.05% |
Mutual Funds | 5.36% | 4.92% | 3.26% | 2.71% |
Insurance Companies | 2.61% | 2.41% | 2.28% | 2.37% |
Foreign Portfolio Investors | 24.35% | 23.27% | 23.06% | 23.8% |
Financial Institutions/ Banks | ||||
Individual Investors | 8.37% | 9.31% | 9.5% | 9.02% |
Others | 4.7% | 5.08% | 6.87% | 7.05% |
Dr. Lal Pathlabs Management
Name | Designation |
---|---|
Brig.(Hony) Dr. Arvind Lal | Executive Chairman |
Dr. Om Prakash Manchanda | Managing Director |
Dr. Vandana Lal | Executive Director |
Mr. Rahul Sharma | Non Executive Director |
Dr. Archana Lal Erdmann | Non Executive Director |
Mr. Sunil Varma | Lead Independent Director |
Mr. Anoop Mahendra Singh | Independent Director |
Mr. Harneet Singh Chandhoke | Independent Director |
Dr. Saurabh Srivastava | Independent Director |
Mrs. Somya Satsangi | Independent Director |
Mr. Rohit Bhasin | Independent Director |
Mr. Arun Duggal | Independent Director |
Mr. Gurinder Singh Kalra | Independent Director |
Mr. Rajit Mehta | Independent Director |
Dr. Lal Pathlabs Forecast
Price Estimates
Dr. Lal Pathlabs Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-11-02 | Quarterly Results | |
2023-07-27 | Quarterly Results & Interim Dividend | |
2023-05-11 | Audited Results & Final Dividend | |
2023-02-02 | Quarterly Results | |
2022-11-08 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-08-11 | FINAL | Rs.6.00 per share(60%)Final Dividend |
2023-08-11 | INTERIM | Rs.6.00 per share(60%)Interim Dividend |
2022-08-09 | INTERIM | Rs.6.00 per share(60%)Interim Dividend |
2022-06-23 | FINAL | Rs.6.00 per share(60%)Final Dividend |
2021-08-22 | INTERIM | Rs.6.00 per share(60%)Interim Dividend |
Dr. Lal Pathlabs FAQs
What is Share Price of Dr. Lal Pathlabs ?
Dr. Lal Pathlabs share price is ₹2,669 As on 30 November, 2023 | 06:30
What is the Market Cap of Dr. Lal Pathlabs ?
The Market Cap of Dr. Lal Pathlabs is ₹22280.3 Cr As on 30 November, 2023 | 06:30
What is the P/E ratio of Dr. Lal Pathlabs ?
The P/E ratio of Dr. Lal Pathlabs is 73.9 As on 30 November, 2023 | 06:30
What is the PB ratio of Dr. Lal Pathlabs ?
The PB ratio of Dr. Lal Pathlabs is 13.1 As on 30 November, 2023 | 06:30